Family Legacy Inc’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$288K Hold
3,000
0.08% 115
2026
Q1
$328K Hold
3,000
0.1% 111
2025
Q4
$243K Hold
3,000
0.07% 116
2025
Q3
$263K Hold
3,000
0.08% 116
2025
Q2
$249K Hold
3,000
0.08% 117
2025
Q1
$252K Hold
3,000
0.09% 114
2024
Q4
$285K Hold
3,000
0.1% 112
2024
Q3
$279K Hold
3,000
0.09% 115
2024
Q2
$247K Buy
+3,000
New +$220K 0.09% 115
2023
Q3
Sell
-3,000
Closed -$202K 115
2023
Q2
$202K Buy
+3,000
New +$183K 0.08% 114
2019
Q1
Sell
-1,000
Closed -$24K 144
2018
Q4
$24K Hold
1,000
0.02% 133
2018
Q3
$39K Hold
1,000
0.03% 127
2018
Q2
$33K Buy
+1,000
New +$35.6K 0.03% 128

Other funds holding LMAT

Family Legacy Inc's LMAT Position: Q2 2026 in Review

Family Legacy Inc held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 3,000 shares worth $288K. The position accounts for 0.08% of the portfolio, ranked #115.

Family Legacy Inc first reported a position in LMAT in Q2 2018 and has held it in 13 quarters since. The position peaked at $328K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Family Legacy Inc held 3,000 shares of LeMaitre Vascular worth $288K as of Q2 2026.
  • Family Legacy Inc left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up 0.08% of Family Legacy Inc's portfolio in Q2 2026, its #115 holding.
  • Family Legacy Inc first reported a position in LeMaitre Vascular in Q2 2018 and has held it in 13 quarters since.
  • Family Legacy Inc's LeMaitre Vascular position peaked at $328K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Family Legacy Inc's 13F filing for Q2 2026, filed 6 Aug 2026.